[1] | World Health Organization. Global Health Observatory. Geneva: World Health Organization; 2018. who.int/gho/database/en. Accessed Feb.16, 2020. |
[2] | Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2018; 68: 394-424. |
[3] | Mbulaiteye SM, Bhatia K, Adebamowo C, Sasco AJ. HIV and Cancer in Africa: Mutual collaboration between HIV and Cancer Programs may provide timely research and Public Health Data. Infect Agent Cancer. 2011; 6(1): 16. |
[4] | Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah A, Abdel-Rahman O. Global, Regional, and National Cancer Incidence, Mortality Years of Life Lost, Years Lived with Disability, and Disability – Adjusted Life – Years for 29 Cancer Groups, 1990 to 2017. JAMA Oncol. doi:10.1001/jamaoncol.2019.2996. Accessed Sept.30, 2019. |
[5] | Parkin D.M, Jemal A, Bray F, Korir A.R, Kamate B, Singh W.Y et al. Cancer in Sub- Saharan Africa Vol.III. UICC; 2019. |
[6] | Dwyer-Lindgren L, Cork MA, Sligar A, Steuben KM, Wilson KF, Provost NR et al. Mapping HIV Prevalence in Sub- Saharan Africa between 2000 and 2017. Nature. 2019; 570: 189-193. https://doi.org/10.1038/s41586-019-1200-9. |
[7] | Chinula L, Moses A, Gopal S. HIV- Associated Malignancies in Sub- Saharan Africa: Progress, Challenges, Opportunities. Curr Opin HIV AIDS. 2017; 12(1): 89- 95. |
[8] | Olafsdottir AE, Reidpath DD, Pokhrel S, Allotey P. Health Systems Performance in Sub Saharan Africa: Governance, Outcome and Equity. BMC Public Health. 2011; 11: 237. https://doi.org/10.1186/1471- 2458-11-237. |
[9] | Odongo K, Kalu O. Does Infrastructure Really Explain Economic Growth in Sub- Saharan Africa? Review of Development Finance. 2016; 6(2): 105-125. https://doi.0rg/10.1016/j.rdf.2016.12.001. |
[10] | Attia- Konan AR, Oga AS, Toure A, Luc Kouadio K. Distribution of out of Pocket Health Expenditures in a Sub Saharan Africa Country: Evidence from the National Survey of Household Standard of Living, Cote d’Ivoire. BMC Res Notes. 2019; 12:25. |
[11] | Naicker S, Plange- Rhule J, Tutt RC, Eastwood JB. Shortage of Healthcare Workers in Developing Countries- Africa. Ethn Dis. 2009; 19(1): S1-60-4. |
[12] | Morhason I O, Odedina F, Rebbeck TR, Harford J, Dangou J, Denny L. Challenges and Opportunities in Cancer Control in Africa: a Perspective from the African Organization for Research and Training in Cancer. Lancet Oncol. 2013; 14: e142-51. |
[13] | Edington G.M, Maclean C.M. A Cancer rate survey in Ibadan, Western Nigeria. Br. J Cancer. 1965; 471-481. |
[14] | Williams A.O, Edington G.M. Malignant disease of the colon, rectum and anal canal in Ibadan, Western Nigeria. Dis Colon Rectum. 1967, 10: 301-3. |
[15] | Abioye AA, The Ibadan Cancer Registry. 1960-1980: Cancer in Africa proceedings of a workshop of the West African College of Physicians: Monrovia, Liberia: 6th-9th July, 1981. |
[16] | Thomas JO. Cancer Registration and Diagnosis in Ibadan. Archives of Ibadan Medicine 2000 April: 1(2):5-6. |
[17] | Lewandowska AM, Rudzki M, Rudzki S, Lewandowski T, Laskowski B. Envirnmental Risk Factors for Cancer. Ann Agric Environ Med. 2019; 26 (1): 1-7. |
[18] | Klassen AC, Platz EA. What can geography tell us about Prostate Cancer? Am J Prev Med. 2006; 30(2): S7-S15. |
[19] | Doll R. The geographical distribution of cancer. British Journal of Cancer. 1969: No.1 Vol.XXIII. |
[20] | Centre for Black Culture and International Understanding. http://www.centreforblackculture.org. Accessed 22nd of November 2019. |
[21] | Federal Republic of Nigeria, National policy on population for sustainable development. Federal Republic of Nigeria official gazette.2009; 96(2): B37. |
[22] | Map of Ijeshaland. www.ogedengbe.com.Accessed 22nd of December 2019. |
[23] | Fritz A, Percy C, Jack A. Shanmugaratnam K, Sobin EH, Parkin DM et al. International Classification of Diseases for Oncology. Geneva: World Health Organization: 2000. |
[24] | Okobia MN. Cancer Care in sub-Saharan Africa-Urgent Need for Population-based Cancer Registries. Ethiop. J. Health Dev.2003; 17(2):89-98. |
[25] | Ogunbiyi JO, Fabowale AO, Ladipo AA. Cancer Incidence and Top Ten Cancers in Eleven Local Government Areas in Ibadan and its Environs, 2004-2008; Ibadan Cancer Registry, Nigeria Technical Report, 2010. |
[26] | Parkin DM, Ferley J, Hamdi-Chevif M, Sitas F, Thomas JO, Wabinga H et al. Cancer in Africa: Epidemiology and Prevention. IARC Publication. IARC Pres Lyon. 2003: No.153. |
[27] | Mulligan T.O. The pattern of malignant disease in Ilesha, Western Nigeria. Br. J Cancer.1970; 25:1-10. |
[28] | Williams A.O. Founder’s Message In: African Cancer Centre, Lagos Nigeria. Brochure 2004; 6-8. |
[29] | Okobia MN, Aligbe JU. Pattern of malignant diseases at the University of Benin Teaching Hospital. Trop Doct. 2005; 35:91-92. |
[30] | Jedy-Agba E, Curado MP, Ogunbiyi O, Oga Emmanuel, Fabowale T, Igbinoga F, Osubor G, Otu T, Kumai H, Koechli A, Osinubi P, Dakum P, Blattner W, Adebamowo CA. Cancer Incidence in Nigeria: A Report from Population-based Cancer Registries. Cancer Epidemiol. 2012; 36(5): e271-278. doi:10.1016/j.canep.2012.04.007. |
[31] | Ekanem IO, Parkin DM. Five year cancer incidence in Calabar, Nigeria (2009-2013). Cancer Epidemiol. 2016; 42: 167-72. |
[32] | Forbes J.F. The incidence of cancer: the global burden, public health consideration. Semin Oncol. 1997; 24: 20-35. |
[33] | Akang EE. Epidemiology of Cancer in Ibadan. Tumours in Childhood. Archives of Ibadan Medicine 2000; 1; 7-9. |
[34] | Tijani SO, Elesha SO, Banjo AA. Morphological patterns of paediatric solid cancers in Lagos, Nigeria. West Afr J Med.1995; 14(3):174-180. |
[35] | Welbeck JE, Hesse AA. Pattern of childhood malignancy in Korle Bu Teaching Hospital, Accra, Ghana. West Afr J Med 1998; 17(2): 81-84. |
[36] | Makata AM, Toriyama K, Kamidigo NO, Eto H, Itakura H. The pattern of Paediatric solid malignant tumours in Western Kenya, 1979-1994: An analysis based on histopathological study. Am J Trop Med Hyg.1996; 54(4): 343-347. |
[37] | Ocheni S, Okafor CO, Emodi J. Spectrum of childhood malignancies in Enugu, Nigeria (1999-2004): Afr J Med Sci. 2005 Dec; 34(4):371-375. |
[38] | Okpala IE, Akang EE, Okpala UJ. Lymphomas in University College Hospital, Ibadan, Nigeria. Cancer. 1991; 68: 1356-136. |
[39] | Orem J, Mbiddle EK, Lambert BO, de Sanjose S, Weiderpass E. Burkitt’s lymphoma in Africa, a review of the epidemiology and aetiology. Afr. Health Sci. 2007; 7(3): 166-175. |
[40] | Grulich AE, Vajdac MC. The epidemiologic of non-Hodgkin lymphoma. Pathology. 2005; 37(6): 406-419. |
[41] | Awofeso O, Roberts AA, Salako O, Balogun L, Okediji P. Prevalence and pattern of late-stage presentation in women with breast and cervical cancers in Lagos University Teaching Hospital, Nigeria. Niger Med J 2018; 59: 74-9. |
[42] | Afolayan A, Olaoye O, Adesina M, Saidu R. Breast cancer trends in a Nigerian population: An analysis of cancer registry data. International Journal of Life Science and Pharma Research. 2012; 12(3): 29-34. |
[43] | White E, Lee Yul C, Kristal M. Evaluation of the increase in breast cancer incidence in relation to mammography use. Natl Cancer Inst. 1990; 82(19): 1546-1552. |
[44] | Miller BA, Feuer EJ, Hankey FB. The increasing incidence of breast cancer since 1982; relevance of early detection. Cancer Causes and Control. 1991; 2: 67-74. |
[45] | Adebamowo CA, Adekunle OO. Case –controlled study of the epidemiological risk factors for breast cancer in Nigeria. British Journal of Surgery. 1999; 86: 665-668. |
[46] | Yankaskas BC. Epidemiology of breast cancer in young women. Breast Disease. 2005-2006; 23:3-8. |
[47] | Jepson AS, Fentman IS. Male breast cancer. Int J Clin Pract. 1998; 52(8): 571-6. |
[48] | Raposo CG, Tevar FZ, Moyano MS, Gomez ML, Casado E. Male breast cancer. Cancer Treatment Review. 2010; 36(6): 451-457. |
[49] | Ezeome ER, Emegoakor CD, Chiamakwana GU, Anyanwu S. The pattern of male breast cancer in eastern Nigeria: A 12 year review. Niger Med J. 2010; 51: 26-9. |
[50] | Kidmas AT, Ugwu BT, Manasseh AN, Iya D, Opaluwa AS. Male breast malignancy in Jos University Teaching Hospital. West Afri. J. Med. 2005; 24: 36-40. |
[51] | Oguntola AS, Aderonmu AOA, Adeoti ML, Olatoke SA, Akanbi O, Agodirin SO. Male Breast Cancer in LAUTECH Teaching Hospital Osogbo, South Western Nigeria. The Nigerian Postgraduate Medical Journal. 2009; 16(2):166-169. |
[52] | Aghadiuno PU. Cancer of the male breast: analysis of forty-three cases in Ibadan, Nigeria. Afr J Med Med Sci. 1987; 16(1): 15-26. |
[53] | Adamu A, Yahaya U, Adamu A, Iliyasu Management and outcomes of male breast cancer in Zaria, Nigeria. International Journal of Breast Cancer. 2012.; 6. https://doi.org/10.1155 12012/8451431. Accessed 29th February, 2020. |
[54] | Enemugwem, R.A., Eze, B.A., Ejike, U, Asuquo E.O, Tobin A. Prostate cancer screening: assessment of knowledge and willingness to screen among men in Obio Akpor LGA, Rivers State, Nigeria. Afr J Urol 2019; 25:11. |
[55] | Ferlay J, Shin HR, Bray F, Forman D, Matters C. Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008. International Journal of Cancer. 2010; 127(12): 2893-2917. |
[56] | Bartal M. Health effects of tobacco use and exposure. Monaldi Arch Chest Dis. 2001; 56 (6):545-554. |